Exane Derivatives Spdr Ser Tr Spdr S&P Biotech E Call Options Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
Call Options
0 transactions
Quarter | Operation | Price Per call | calls change | calls Held | SEC Form |
---|
Others Institutions Holding XBI
# of Institutions
894Shares Held
94.6MCall Options Held
18.4MPut Options Held
31.6M-
Jpmorgan Chase & CO New York, NY12.3MShares$1.21 Billion0.1% of portfolio
-
Goldman Sachs Group Inc New York, NY12MShares$1.17 Billion0.19% of portfolio
-
Bank Of America Corp Charlotte, NC8.98MShares$881 Million0.07% of portfolio
-
Citigroup Inc7.26MShares$712 Million0.44% of portfolio
-
Morgan Stanley New York, NY6.41MShares$629 Million0.05% of portfolio